Test and Optimization of New Specific MRI Sequences on an Imager Dedicated to Research

Overview

Magnetic Resonance Imaging (MRI) performance depends on equipment performance, equipment maintenance and relevance of MRI sequence used. To optimize MRI performance, it's necessary to develop, optimize, test and validate new acquisition sequences for enhanced diagnosis and therapy monitoring. These new sequences will allow better spatial resolution and specificity while reducing acquisition time.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 2023

Detailed Description

The purpose of the present study is to test and optimize, on healthy subjects, specific MRI acquisition sequences firstly developed in a preclinical phase on phantoms (inert objects containing solutions or gels) and animal (Pig, sheep). This study will allow the investigators to define practical acquisition parameters that will allow reproducible results and precise definition of clinically relevant examination protocols for each new developed sequence.

Interventions

  • Device: MRI acquisitions
    • Procedure of the study is an MRI exam without any injection or invasive procedure, that will be performed on the Siemens Magnetom Aera imager of Liryc institute (L’Institut de RYthmologie et modélisation Cardiaque) (Xavier Arnozan site – Bordeaux)

Arms, Groups and Cohorts

  • Experimental: MRI
    • MRI exam performed on 200 healthy volunteers

Clinical Trial Outcome Measures

Primary Measures

  • Image quality
    • Time Frame: Day 0
  • Signal to noise ratio
    • Time Frame: Day 0
  • Contrasts between structurally different regions
    • Time Frame: Day 0
    • The values of the signal intensities will be measured in adjacent structures of interest. The difference between these values divided by the noise will be calculated to quantify the contrast-to-noise ratio between these structures. The higher this value is, the better is the sequence in its ability to differentiate these structures from one another.
  • Total acquisition time
    • Time Frame: Day 0
  • Qualitative interpretation of image quality to respiratory and cardiac motions
    • Time Frame: Day 0
    • In the presence of improper compensation for cardiac and / or respiratory movements, the images may appear blurred. The qualitative interpretation of image quality will be performed by visual image analysis.
  • Quantitative interpretation of image quality to respiratory and cardiac motions
    • Time Frame: Day 0
    • In the presence of improper compensation for cardiac and / or respiratory movements, the images may appear blurred. The quantitative interpretation of image quality will be performed by a measurement of sharpness of contours between adjacent structures of interest.

Participating in This Clinical Trial

Inclusion Criteria

  • Healthy volunteers (over 18 yo), – Male or female, – Affiliated to social security, – Without any contraindication to MRI exam and who will have signed a written inform consent. Exclusion Criteria:

  • Individuals deprived of liberty, – Under guardianship or curatorship, – Persons with known disease which could disturb MRI acquisition or with absolute or relative contraindication to an MRI examination – Pregnant women, – Breastfeeding women, – Women without effective contraception, – Participants who refused to be informed of the possible discovery of a significant anomaly, – Persons involved in an interventional study with a drug or an implantable device.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University Hospital, Bordeaux
  • Collaborator
    • L’Institut de RYthmologie et modélisation Cardiaque (IHU LIRYC)
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Hubert COCHET, MD, Principal Investigator, University Hospital, Bordeaux
  • Overall Contact(s)
    • Hubert COCHET, MD, (0)557675613, hubert.cochet@chu-bordeaux.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.